TRAF6 and myocardial infarction: By upregulating miR-125a-5p and inhibiting the TRAF6/IRF5 signaling pathway, macrophage polarization toward the M2 phenotype is promoted, reducing the inflammatory response after myocardial infarction, improving cardiac function and structure, and alleviating AMI.